Tag: Lumasiran

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Lumasiran

Alnylam wins US approval for its third rare disease drug

Added to Collection on: 2020-11-24 15:45:00

Tags for this article:

Orphan drugs
Health care
Medicine
Health sciences
Lumasiran
Primary hyperoxaluria
Alnylam Pharmaceuticals
Hyperoxaluria
Givosiran
Oxalate
Food and Drug Administration
Dialysis

Click the tags to see associated articles and topics

View Article Details
Covid-19 roundup: Russia prices vaccine 'two or more times cheaper' than mRNA shots; Sinovac ...

Added to Collection on: 2020-11-24 12:44:45

Tags for this article:

Kidney diseases
Medical specialties
Clinical medicine
Medicine
Primary hyperoxaluria
Orphan drugs
Hyperoxaluria
Lumasiran
Alnylam Pharmaceuticals
Oxalate
Kidney stone disease

Click the tags to see associated articles and topics

View Article Details
Alnylam's RNAi Therapies Make It A Buy

Added to Collection on: 2020-11-28 12:11:15

Tags for this article:

Nucleic acids
Branches of biology
Life Sciences
RNA
Molecular biology
Gene expression
Molecular genetics
Alnylam Pharmaceuticals
Moderna
Sanofi
RNA interference
Lumasiran

Click the tags to see associated articles and topics

View Article Details
Alnylam Launches "Alnylam P5x25" Strategy for Planned Transition to a Top Five Biotech in Market ...

Added to Collection on: 2021-01-10 18:00:00

Tags for this article:

Branches of biology
Life Sciences
Biology
RNA
Gene expression
Molecular biology
Alnylam Pharmaceuticals
Therapeutic gene modulation
Small interfering RNA
Inclisiran
Lumasiran
Novartis
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details
Novel Agents Promising in Pruritus, Rare Metabolic Disease, and More | MedPage Today

Added to Collection on: 2022-04-10 20:04:12

Tags for this article:

Medicine
Clinical medicine
Chemistry
Kidney diseases
Membrane technology
Primary hyperoxaluria
Organ failure
Renal dialysis
Sodium zirconium cyclosilicate
Chronic kidney disease
Lumasiran
Hemodialysis
Daniel Weiner

Click the tags to see associated articles and topics

View Article Details
Alnylam (ALNY) Misses on Q1 Earnings, Lowers '22 Revenue View - April 29, 2022 - Zacks

Added to Collection on: 2022-04-29 16:44:02

Tags for this article:

Life Sciences
Health sciences
Health care
RNA interference
Orphan drugs
Alnylam Pharmaceuticals
Therapeutic gene modulation
Patisiran
Lumasiran
Small interfering RNA
Regeneron Pharmaceuticals
Novartis
Alnylam Pharmaceuticals Inc.

Click the tags to see associated articles and topics

View Article Details